HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Yan Selected Research

medicarpin

2/2022Medicarpin Protects Cerebral Microvascular Endothelial Cells Against Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury via the PI3K/Akt/FoxO Pathway: A Study of Network Pharmacology Analysis and Experimental Validation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Yan Research Topics

Disease

68Neoplasms (Cancer)
01/2022 - 02/2005
32Brain Injuries (Brain Injury)
01/2022 - 03/2009
22Inflammation (Inflammations)
06/2022 - 01/2005
22Breast Neoplasms (Breast Cancer)
07/2021 - 02/2004
20Brain Ischemia (Cerebral Ischemia)
07/2022 - 05/2009
20Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2022 - 05/2013
18Carcinoma (Carcinomatosis)
01/2022 - 10/2003
17Brain Edema (Cerebral Edema)
06/2022 - 05/2013
15Neuroinflammatory Diseases
08/2022 - 10/2017
15Stroke (Strokes)
01/2022 - 07/2013
14Ischemic Stroke
02/2022 - 03/2012
12Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2020 - 05/2009
11Infections
01/2022 - 03/2005
11Ischemia
06/2018 - 03/2009
10Stomach Neoplasms (Stomach Cancer)
12/2021 - 03/2012
10Carcinogenesis
07/2021 - 02/2013
10Neoplasm Metastasis (Metastasis)
06/2021 - 03/2008
10Infarction (Infarctions)
12/2019 - 05/2009
9Cerebral Hemorrhage
08/2022 - 03/2012
8Body Weight (Weight, Body)
01/2022 - 10/2002
8Reperfusion Injury
06/2018 - 06/2011
7Thrombosis (Thrombus)
12/2021 - 11/2009
7Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 01/2012
6Ovarian Neoplasms (Ovarian Cancer)
06/2021 - 03/2012
6Wounds and Injuries (Trauma)
10/2019 - 09/2010
6Hepatocellular Carcinoma (Hepatoma)
12/2014 - 03/2009
5Hypoxia (Hypoxemia)
06/2022 - 10/2008
5Cognitive Dysfunction
01/2022 - 01/2018
5Hematoma
12/2021 - 03/2012
5Cerebral Infarction
08/2020 - 03/2009
4Fibrosis (Cirrhosis)
03/2022 - 10/2011
4Hemorrhage
01/2022 - 09/2017
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 01/2013
4Thrombocytopenia (Thrombopenia)
12/2021 - 06/2011
4Alzheimer Disease (Alzheimer's Disease)
01/2021 - 11/2015
4Obesity
01/2021 - 01/2016
4Hypertension (High Blood Pressure)
01/2021 - 03/2009
4Hemolysis
10/2019 - 10/2015
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 06/2010
4Hypothermia
12/2018 - 05/2010
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016 - 01/2011
3Bacterial Infections (Bacterial Infection)
06/2022 - 10/2020
3Non-alcoholic Fatty Liver Disease
03/2022 - 12/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 09/2012
3Traumatic Brain Injuries (Traumatic Brain Injury)
07/2021 - 10/2019
3Glioma (Gliomas)
01/2021 - 08/2014
3Weight Gain
01/2021 - 01/2016
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 11/2013
3Necrosis
01/2021 - 01/2014
3Osteosarcoma (Osteogenic Sarcoma)
02/2020 - 08/2013

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2005
24Biomarkers (Surrogate Marker)IBA
03/2022 - 03/2012
17Neuroprotective AgentsIBA
01/2022 - 05/2009
14MicroRNAs (MicroRNA)IBA
11/2021 - 01/2013
13Pharmaceutical PreparationsIBA
06/2022 - 05/2009
13Messenger RNA (mRNA)IBA
01/2022 - 03/2008
11Small Interfering RNA (siRNA)IBA
01/2021 - 04/2011
10Long Noncoding RNAIBA
01/2022 - 01/2016
10DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2002
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 02/2004
9AntioxidantsIBA
01/2022 - 09/2012
9AntigensIBA
01/2017 - 08/2007
8Glucose (Dextrose)FDA LinkGeneric
07/2022 - 02/2015
8CytokinesIBA
06/2022 - 01/2011
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2014
8LipidsIBA
01/2021 - 05/2010
8UbiquitinIBA
01/2019 - 02/2013
8Carcinoembryonic AntigenIBA
01/2018 - 08/2007
6RNA (Ribonucleic Acid)IBA
01/2021 - 11/2006
6Caspase 3 (Caspase-3)IBA
01/2019 - 07/2010
6AntibodiesIBA
05/2015 - 08/2007
5CollagenIBA
06/2022 - 09/2015
5CarbonIBA
06/2022 - 02/2005
5LipopolysaccharidesIBA
06/2022 - 01/2019
5Transfer RNA (tRNA)IBA
01/2022 - 04/2019
5InflammasomesIBA
01/2022 - 05/2016
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 08/2014
5Biological ProductsIBA
07/2021 - 08/2014
5Phosphotransferases (Kinase)IBA
07/2021 - 06/2012
5Coloring Agents (Dyes)IBA
04/2021 - 05/2013
5ErythropoietinFDA Link
01/2021 - 05/2009
4Oxygen (Dioxygen)IBA
06/2022 - 06/2018
4Transcription Factors (Transcription Factor)IBA
01/2021 - 03/2013
4MelatoninIBA
01/2017 - 01/2014
4Protein Kinases (Protein Kinase)IBA
01/2017 - 03/2009
4Complementary DNA (cDNA)IBA
10/2009 - 11/2002
3Tight Junction ProteinsIBA
01/2022 - 10/2014
3Inosine Triphosphate (ITP)IBA
01/2022 - 01/2013
3NADPH Oxidases (NAD(P)H oxidase)IBA
12/2021 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
12/2021 - 10/2012
3CholesterolIBA
01/2021 - 10/2011
3AnticoagulantsIBA
01/2021 - 02/2019
3AntagomirsIBA
08/2020 - 08/2015
3TeaIBA
04/2020 - 01/2018
3Circular RNAIBA
01/2020 - 04/2017

Therapy/Procedure

25Therapeutics
06/2022 - 10/2003
10Drug Therapy (Chemotherapy)
01/2020 - 06/2010
6Ischemic Postconditioning
01/2018 - 03/2012
4Immunotherapy
01/2021 - 01/2018
4Transplantation
01/2021 - 01/2014